| 注册
首页|期刊导航|中国医学科学院学报|NLRP3炎症小体与糖尿病慢性并发症的关系及中药干预作用

NLRP3炎症小体与糖尿病慢性并发症的关系及中药干预作用

孙青 梁晓春

中国医学科学院学报2018,Vol.40Issue(1):116-121,6.
中国医学科学院学报2018,Vol.40Issue(1):116-121,6.DOI:10.3881/j.issn.1000-503X.2018.01.018

NLRP3炎症小体与糖尿病慢性并发症的关系及中药干预作用

Relationship between NLRP3 Inflammasome and Chronic Complications of Diabetes and Therapeutic Effects of Chinese Herbal Medicine

孙青 1梁晓春1

作者信息

  • 1. 中国医学科学院北京协和医学院北京协和医院中医科,北京100730
  • 折叠

摘要

Abstract

NLRP3 inflammasome is a pattern recognition receptor that regulates the maturation and secretion of proinflammatory cytokines including interleukin (IL)-1β and IL-18 by activating the cysteine-containing aspartic acid protease and thus induces inflammatory response.Mtabolic stress including hyperglycemia,high blood free fatty acids,and hyperuricemia can activate NLRP3 inflammasome.Thus,NLRP3 inflammasome has became a new target in the treatment of diabetes and its chronic complications.This article reviews the relationship between NLRP3 inflammasome and chronic complications of diabetes and the therapeutic effects of Chinese herbal medicine.

关键词

NLRP3炎症小体/糖尿病慢性并发症/中药

Key words

NLRP3 inflammasome/chronic complications of diabetes/Chinese herbal medicine

分类

医药卫生

引用本文复制引用

孙青,梁晓春..NLRP3炎症小体与糖尿病慢性并发症的关系及中药干预作用[J].中国医学科学院学报,2018,40(1):116-121,6.

基金项目

国家自然科学基金(81603481)和北京协和医院中青年科研基金(pumch-2013-140) Supported by the National Natural Sciences Foundation of China (81603481) and the Youth Science Foundation of PUMCH (pumch-2013-140) (81603481)

中国医学科学院学报

OA北大核心CSCDCSTPCDMEDLINE

1000-503X

访问量0
|
下载量0
段落导航相关论文